Suppr超能文献

从丁香糖丝菌NRRL B-16468中鉴定诺卡霉素生物合成基因簇并通过操纵基因簇生成新的诺卡霉素衍生物。

Identification of nocamycin biosynthetic gene cluster from Saccharothrix syringae NRRL B-16468 and generation of new nocamycin derivatives by manipulating gene cluster.

作者信息

Mo Xuhua, Shi Chunrong, Gui Chun, Zhang Yanjiao, Ju Jianhua, Wang Qingji

机构信息

Shandong Key Laboratory of Applied Mycology, School of Life Sciences, Qingdao Agricultural University, Qingdao, 266109, China.

CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, RNAM Center for Marine Microbiology, South China Sea Institute of Oceanology, Chinese Academy of Sciences, 164 West Xingang Rd., Guangzhou, 510301, China.

出版信息

Microb Cell Fact. 2017 Jun 9;16(1):100. doi: 10.1186/s12934-017-0718-5.

Abstract

BACKGROUND

Nocamycins I and II, produced by the rare actinomycete Saccharothrix syringae, belong to the tetramic acid family natural products. Nocamycins show potent antimicrobial activity and they hold great potential for antibacterial agent design. However, up to now, little is known about the exact biosynthetic mechanism of nocamycin.

RESULTS

In this report, we identified the gene cluster responsible for nocamycin biosynthesis from S. syringae and generated new nocamycin derivatives by manipulating its gene cluster. The biosynthetic gene cluster for nocamycin contains a 61 kb DNA locus, consisting of 21 open reading frames (ORFs). Five type I polyketide synthases (NcmAI, NcmAII, NcmAIII, NcmAIV, NcmAV) and a non-ribosomal peptide synthetase (NcmB) are proposed to be involved in synthesis of the backbone structure, a Dieckmann cyclase NcmC catalyze the releasing of linear chain and the formation of tetramic acid moiety, five enzymes (NcmEDGOP) are related to post-tailoring steps, and five enzymes (NcmNJKIM) function as regulators. Targeted inactivation of ncmB led to nocamycin production being completely abolished, which demonstrates that this gene cluster is involved in nocamycin biosynthesis. To generate new nocamycin derivatives, the gene ncmG, encoding for a cytochrome P450 oxidase, was inactivated. Two new nocamycin derivatives nocamycin III and nocamycin IV were isolated from the ncmG deletion mutant strain and their structures were elucidated by spectroscopic data analyses. Based on bioinformatics analysis and new derivatives isolated from gene inactivation mutant strains, a biosynthetic pathway of nocamycins was proposed.

CONCLUSION

These findings provide the basis for further understanding of nocamycin biosynthetic mechanism, and set the stage to rationally engineer new nocamycin derivatives via combinatorial biosynthesis strategy.

摘要

背景

由稀有放线菌丁香糖丝菌产生的诺卡霉素I和II属于四胺酸家族天然产物。诺卡霉素具有强大的抗菌活性,在抗菌剂设计方面具有巨大潜力。然而,截至目前,关于诺卡霉素的确切生物合成机制知之甚少。

结果

在本报告中,我们从丁香糖丝菌中鉴定出负责诺卡霉素生物合成的基因簇,并通过操纵其基因簇产生了新的诺卡霉素衍生物。诺卡霉素的生物合成基因簇包含一个61 kb的DNA位点,由21个开放阅读框(ORF)组成。推测五个I型聚酮合酶(NcmAI、NcmAII、NcmAIII、NcmAIV、NcmAV)和一个非核糖体肽合成酶(NcmB)参与骨架结构的合成,一个迪克曼环化酶NcmC催化线性链的释放和四胺酸部分的形成,五种酶(NcmEDGOP)与后修饰步骤相关,五种酶(NcmNJKIM)起调节作用。对ncmB进行靶向失活导致诺卡霉素的产生完全被消除,这表明该基因簇参与诺卡霉素的生物合成。为了产生新的诺卡霉素衍生物,对编码细胞色素P450氧化酶的基因ncmG进行了失活。从ncmG缺失突变株中分离出两种新的诺卡霉素衍生物诺卡霉素III和诺卡霉素IV,并通过光谱数据分析阐明了它们的结构。基于生物信息学分析和从基因失活突变株中分离出的新衍生物,提出了诺卡霉素的生物合成途径。

结论

这些发现为进一步理解诺卡霉素的生物合成机制提供了基础,并为通过组合生物合成策略合理改造新的诺卡霉素衍生物奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6418/5466765/d1f9d1e95130/12934_2017_718_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验